Rudralife Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.98 M
as on 16-11-2024
- Revenue 62.81%
(FY 2023)
- Profit 18.53%
(FY 2023)
- Ebitda 609.40%
(FY 2023)
- Net Worth 30.19%
(FY 2023)
- Total Assets 71.19%
(FY 2023)
About Rudralife Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.98 M.
Pushpendra Singh and Yogendra Singh serve as directors at the Company.
- CIN/LLPIN
U93000UR2018PTC008614
- Company No.
008614
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Rudralife Science Private Limited offer?
Rudralife Science Private Limited offers a wide range of products and services, including Ayurvedic Digestive Medicine, Digestive Enzyme Syrup, Antacid Drugs, Rabeprazole Domperidone Capsule, Pantoprazole Drugs, Pantoprazole & Domperidone Capsules, Antihistamines, Levocetirizine Tablet, Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Rudralife Science?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpendra Singh  | Director | 05-Apr-2018 | Current |
| Yogendra Singh | Director | 05-Apr-2018 | Current |
Financial Performance of Rudralife Science.
Rudralife Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.81% increase. The company also saw a substantial improvement in profitability, with a 18.53% increase in profit. The company's net worth Soared by an impressive increase of 30.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rudralife Science?
In 2023, Rudralife Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Villmed Laboratories Private LimitedActive 6 years 9 monthsPushpendra Singh and Yogendra Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 18 Oct 2018 | ₹0.98 M | Open |
How Many Employees Work at Rudralife Science?
Unlock and access historical data on people associated with Rudralife Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rudralife Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rudralife Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
